CITIGROUP INC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 46 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$172,006
-50.0%
200,000
-50.0%
0.00%
Q1 2023$343,796
-61.0%
400,000
-60.0%
0.00%
-100.0%
Q4 2022$881,900
-3.7%
1,000,000
-2.4%
0.00%0.0%
Q3 2022$916,000
+4.4%
1,025,0000.0%0.00%0.0%
Q2 2022$877,000
+295.0%
1,025,000
+318.4%
0.00%
Q1 2022$222,000
-96.0%
245,000
-95.9%
0.00%
-100.0%
Q4 2021$5,483,0006,000,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q1 2022
NameSharesValueWeighting ↓
BRAIDWELL LP 134,334,000$116,802,1483.85%
STEELHEAD PARTNERS LLC 46,562,000$40,485,6592.64%
DeepCurrents Investment Group LLC 40,000,000$34,578,4961.35%
WOLVERINE ASSET MANAGEMENT LLC 76,557,000$66,300,8520.78%
SHENKMAN CAPITAL MANAGEMENT INC 11,317,000$9,786,5210.74%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,856,000$4,199,9000.62%
Ionic Capital Management LLC 2,000,000$1,726,3490.50%
Empyrean Capital Partners, LP 15,000,000$12,980,0000.44%
Context Capital Management, LLC 4,489$3,9030.33%
Graham Capital Management, L.P. 11,422,000$9,875,7460.30%
View complete list of NOVOCURE LTD shareholders